Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Institute of Psychiatry, Psychology and Neuroscience

    - PMLiVE

    WHO urges US to ‘reconsider’ withdrawal from global health organisation

    President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises

    - PMLiVE

    WHO launches $1.5bn emergency appeal to tackle ongoing health crises

    The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people

    - PMLiVE

    WHO announces priority endemic pathogens for urgent vaccine development

    The study identifies the 17 pathogens that regularly cause diseases in communities

    - PMLiVE

    Moderna’s JN.1-adapted COVID-19 vaccine approved by MHRA for adults and children

    The JCVI has already advised the UK government on eligible groups for this year’s autumn vaccination programme

    - PMLiVE

    Novavax’s JN.1-adapted COVID-19 vaccine granted FDA emergency use authorisation

    JN.1 only accounts for 0.2% of cases across the country but is the ‘parent strain’ of currently circulating variants

    - PMLiVE

    FDA approves updated COVID-19 vaccines to better protect against current variants

    Adapted vaccines from Pfizer/BioNTech and Moderna have been authorised for individuals aged six months and older

    - PMLiVE

    WHO announces new mRNA vaccine development initiative against human avian influenza

    H5N1 was responsible for 889 cases and 463 deaths across 23 countries from 2003 to 2024

    - PMLiVE

    JCVI announces advice for autumn COVID-19 vaccination programme eligibility

    The Committee has advised offering the vaccine to those at high risk of serious disease

    - PMLiVE

    WHO and CEPI call for broader research strategy to prepare for future pandemics

    They have highlighted the importance of expanding research to entire families of pathogens

    - PMLiVE

    WHO calls for better medicines access to close neurological disorders treatment gap

    In 2021, neurological conditions affected more than three billion people worldwide

    - PMLiVE

    WHO publishes guidance for HPV vaccine developers to help tackle cervical cancer

    In more than nine out of ten cases, the HPV virus leads to cervical cancer, the fourth most common cancer in women globally

    - PMLiVE

    WHO publishes new toolkit to improve services for neurological disorders

    Neurological conditions such as dementia and stroke were responsible for more than three billion cases globally in 2021

    2025 T40 open for submissions
    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links